NEW YORK, NY / ACCESSWIRE / February 11, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court.
Databridgemarketresearch.com Present “
Global Digital Pills Market– Industry Trends and Forecast to 2028” new report to its research database. Due to the potential of SWOT analysis and Porter’s Five Forces analysis in generating market research report, they are preferred by the businesses and hence also used while making this report. To structure such a world-class report, the combination of best industry insight, practical solutions, talent solutions and latest technology have been used. As today’s businesses demand the market research analysis to a great extent before taking any verdict about the products, choosing such market research report is essential for the businesses. DBMR team is committed to present the market research report that is promising and the way in which it is foreseen.
LOS ANGELES, CA / ACCESSWIRE / February 6, 2021 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against iRhythm Technologies, Inc. ("iRhythm" or "the Company") (NASDAQ:IRTC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.
NEW YORK, Feb. 03, 2021 (GLOBE NEWSWIRE) Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of AstraZeneca PLC (NASDAQ: AZN) and iRhythm Technologies, Inc. (NASDAQ: IRTC). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided. AstraZeneca PLC (NASDAQ: AZN) Class Period: May 21, 2020 to November 20, 2020 Lead Plaintiff Deadline: March 29, 2021 AstraZeneca is one of the largest biopharmaceutical companies in the world and was one of the early front-runners in the race to develop a COVID-19 vaccine. In April 2020, the Company partnered with Oxford University to develop a potential recombinant adenovirus vaccine for the virus, later dubbed AZD1222. On November 23, 2020, AstraZeneca issued a release announcing the results of an interim analysis of its ongoing t
30.12.2020 - SAN FRANCISCO, Dec. 29, 2020 (GLOBE NEWSWIRE) - iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital health care solutions company focused on the advancement of cardiac care, today announced the company will be participating in the .